Christopher J. Yuskaitis

3.0k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

Christopher J. Yuskaitis is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christopher J. Yuskaitis has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 11 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christopher J. Yuskaitis's work include Epilepsy research and treatment (14 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Christopher J. Yuskaitis is often cited by papers focused on Epilepsy research and treatment (14 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Christopher J. Yuskaitis collaborates with scholars based in United States, Australia and Chile. Christopher J. Yuskaitis's co-authors include Richard S. Jope, Eléonore Beurel, Marjelo A. Mines, Margaret K. King, Annapurna Poduri, J. David Sweatt, Courtney A. Miller, Mustafa Şahin, Shengqiang Chen and Robert Bauchwitz and has published in prestigious journals such as PLoS ONE, Neurology and PEDIATRICS.

In The Last Decade

Christopher J. Yuskaitis

30 papers receiving 1.7k citations

Hit Papers

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Yuskaitis United States 16 914 588 320 309 265 31 1.7k
Arnaud Duchon France 23 693 0.8× 619 1.1× 163 0.5× 185 0.6× 81 0.3× 33 1.8k
Yi‐Wu Shi China 22 682 0.7× 642 1.1× 174 0.5× 453 1.5× 537 2.0× 58 1.7k
Nicholas Rensing United States 24 971 1.1× 329 0.6× 170 0.5× 626 2.0× 367 1.4× 44 2.4k
Wei‐Ping Liao China 30 1.2k 1.3× 1.1k 1.8× 288 0.9× 684 2.2× 918 3.5× 122 2.7k
Chi‐Tso Chiu Taiwan 23 1.2k 1.3× 333 0.6× 104 0.3× 691 2.2× 367 1.4× 37 2.4k
Russell J. Buono United States 23 847 0.9× 352 0.6× 109 0.3× 723 2.3× 381 1.4× 66 1.6k
Daniel M. Fass United States 22 2.1k 2.3× 561 1.0× 169 0.5× 680 2.2× 105 0.4× 35 2.8k
Yunfei Huang United States 17 1.0k 1.1× 321 0.5× 71 0.2× 561 1.8× 165 0.6× 29 1.8k
Ren‐Wu Chen United States 17 970 1.1× 294 0.5× 65 0.2× 657 2.1× 386 1.5× 20 2.0k
Jean Maurice Delabar France 23 851 0.9× 808 1.4× 139 0.4× 84 0.3× 77 0.3× 48 1.9k

Countries citing papers authored by Christopher J. Yuskaitis

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Yuskaitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Yuskaitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Yuskaitis more than expected).

Fields of papers citing papers by Christopher J. Yuskaitis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Yuskaitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Yuskaitis. The network helps show where Christopher J. Yuskaitis may publish in the future.

Co-authorship network of co-authors of Christopher J. Yuskaitis

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Yuskaitis. A scholar is included among the top collaborators of Christopher J. Yuskaitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Yuskaitis. Christopher J. Yuskaitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Amore, Angelica, Maria Sundberg, Rui Lin, et al.. (2025). Phenotypic rescue via mTOR inhibition in neuron-specific Pten knockout mice reveals AKT and mTORC1-site specific changes. Molecular Psychiatry. 30(7). 3077–3089.
2.
Singh, Avantika, Catherine L. Salussolia, Alexander L. Cohen, et al.. (2024). Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience. Epilepsia. 65(4). 984–994. 2 indexed citations
3.
Gupta, Nishtha, Avantika Singh, Christopher M. Ryan, et al.. (2023). Delays to care in infantile epileptic spasms syndrome: Racial and ethnic inequities. Epilepsia. 65(1). 107–114. 4 indexed citations
4.
Harini, Chellamani, Christopher J. Yuskaitis, Avantika Singh, et al.. (2023). Hospital readmissions in children with new‐onset infantile epileptic spasms syndrome. Epilepsia Open. 8(2). 444–455. 1 indexed citations
5.
Yuskaitis, Christopher J., Michael R. MacArthur, Sarah J. Mitchell, et al.. (2022). The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth. Cell Reports. 39(7). 110824–110824. 8 indexed citations
6.
Yuskaitis, Christopher J., Leigh‐Ana Rossitto, Divakar S. Mithal, et al.. (2022). DEPDC5-dependent mTORC1 signaling mechanisms are critical for the anti-seizure effects of acute fasting. Cell Reports. 40(9). 111278–111278. 15 indexed citations
7.
Yuskaitis, Christopher J., John R. Mytinger, Fiona M. Baumer, et al.. (2022). Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms. Neurology. 99(22). e2494–e2503. 12 indexed citations
8.
Harini, Chellamani, Christopher J. Yuskaitis, Mark H. Libenson, et al.. (2021). Hippocampal Involvement With Vigabatrin-Related MRI Signal Abnormalities in Patients With Infantile Spasms: A Novel Finding. Journal of Child Neurology. 36(7). 575–582. 1 indexed citations
9.
Fernández, Iván Sánchez, Marta Amengual‐Gual, Marina Gaínza‐Lein, et al.. (2021). Cost‐effectiveness of adrenocorticotropic hormone versus oral steroids for infantile spasms. Epilepsia. 62(2). 347–357. 22 indexed citations
10.
Harini, Chellamani, Elanagan Nagarajan, Ann M. Bergin, et al.. (2020). Mortality in infantile spasms: A hospital‐based study. Epilepsia. 61(4). 702–713. 24 indexed citations
11.
Yuskaitis, Christopher J., et al.. (2019). Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice. Human Molecular Genetics. 28(17). 2952–2964. 39 indexed citations
12.
Yuskaitis, Christopher J., et al.. (2019). Brain MRI abnormalities in patients with infantile spasms and Down syndrome. Epilepsy & Behavior. 92. 57–60. 10 indexed citations
13.
Yuskaitis, Christopher J., Maura Ruzhnikov, Katherine B. Howell, et al.. (2018). Infantile Spasms of Unknown Cause: Predictors of Outcome and Genotype-Phenotype Correlation. Pediatric Neurology. 87. 48–56. 47 indexed citations
14.
Harini, Chellamani, Ann M. Bergin, Annapurna Poduri, et al.. (2018). Detailed Magnetic Resonance Imaging (MRI) Analysis in Infantile Spasms. Journal of Child Neurology. 33(6). 405–412. 19 indexed citations
15.
Yuskaitis, Christopher J., Brandon Jones, Rachel L. Wolfson, et al.. (2017). A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility. Neurobiology of Disease. 111. 91–101. 73 indexed citations
16.
Yuskaitis, Christopher J., et al.. (2015). Neural Mechanisms Underlying Musical Pitch Perception and Clinical Applications Including Developmental Dyslexia. Current Neurology and Neuroscience Reports. 15(8). 51–51. 9 indexed citations
17.
Mines, Marjelo A., Christopher J. Yuskaitis, Margaret K. King, Eléonore Beurel, & Richard S. Jope. (2010). GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism. PLoS ONE. 5(3). e9706–e9706. 173 indexed citations
18.
Yuskaitis, Christopher J. & Richard S. Jope. (2008). Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cellular Signalling. 21(2). 264–273. 201 indexed citations
19.
Yuskaitis, Christopher J., et al.. (2008). Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential. Neuropharmacology. 56(2). 463–472. 114 indexed citations
20.
Jope, Richard S., Christopher J. Yuskaitis, & Eléonore Beurel. (2006). Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics. Neurochemical Research. 32(4-5). 577–595. 658 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026